International Conference on CRISPR Technologies

Session: Genome editing and gene regulation in human health

Presentations

01:15 AM

Gene Repression Via CRISPR-Assisted Modification of Specific Chromatin Marks

Holtzman, L., Rathinavelu, J., Gersbach, C. A.

01:40 AM

CRISPR-Based Synthetic Gene Circuits for Controllable Gene Therapies

02:05 AM

RNA Secondary Structure Increases the Specificity of Class 2 CRISPR Effectors

Kocak, D. D., Josephs, E. A., Kwon, J. B., Adkar, S. S., Fitzgibbon, C. J., Klann, T. S., Thakore, P. I., Marszalek, P. E., Gersbach, C. A.

02:30 AM

Engineered Stem Cell Models to Reconstitute Kidney Function and Disease

Musah, S., Ingber, D. E., Church, G. M.

02:55 AM

Computational Selection of CRISPR/Cas9 Guide-RNAs to Target Highly Variable Integrated HIV-1 Provirus Using Next Generation Sequencing

Dampier, W., Nonnemacher, M., Chung, C. H., Allen, A., Sullivan, N., Pirrone, V., Kercher, K., Passic, S., Williams, J., Wigdahl, B.

12:00 PM

A Novel Cas9 Mutant Confers Reduced Off-Target Gene Editing While Maintaining on-Target Potency

Cannieux, M., Rettig, G., Thommandru, B., Jacobi, A., Collingwood, M., Schubert, M., Behlke, M., Vakulskas, C., Lister, J.

12:25 PM

Fluorescent Guide RNAs for Understanding Grnas Expressed from Pol II Promoters

Menn, D., Ebrahimkhani, M., Wang, X., Kiani, S.

12:50 PM

Enhancer Composition and Dosage Control Developmental Gene Expression

Will, A., Cova, G., Osterwalder, M., Chan, W. L., Wittler, L., Brieske, N., Heinrich, V., De Villartay, J. P., Vingron, M., Visel, A., Klopocki, E., Lupiáñez, D., Mundlos, S.